Telomir Pharmaceuticals, Inc.

Current report filing

Certification by an exchange approving securities for listing

Notice of Effectiveness

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

Exempt (Private) Offering

Bay Shore Trust: Statement of changes in beneficial ownership of securities

Fuentes Nathen: Initial statement of beneficial ownership of securities

Tuck Talhia: Initial statement of beneficial ownership of securities

Chapman Christopher C JR: Initial statement of beneficial ownership of securities

Bay Shore Trust: Initial statement of beneficial ownership of securities

Nicholoudis Christos: Initial statement of beneficial ownership of securities

EAGLE CRAIG: Initial statement of beneficial ownership of securities

Kroenig Bradley: Initial statement of beneficial ownership of securities

Jerman Michael Allen: Initial statement of beneficial ownership of securities

McColl Hugh III: Initial statement of beneficial ownership of securities

Prospectus filed pursuant to Rule 424(b)(1)

Prospectus filed pursuant to Rule 424(b)(4)

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy